Guerbet stock falls after H1 profit margin erosion
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Guerbet (GRBT)
Guerbet stock price live, this page displays EPA GRBT stock exchange data. View the GRBT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Guerbet real time stock price chart below.
What Is the Guerbet Stock Price Today?
The Guerbet stock price today is 14.00.
What Is the Stock Symbol for Guerbet?
The stock symbol for Guerbet is ""GRBT.""
What Stock Exchange Does Guerbet Trade On?
Guerbet is listed and trades on the Paris stock exchange.
Is Guerbet a Good Stock to Buy?
Determining whether Guerbet—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRBT quote. (ISIN: FR0000032526)
What Is the Guerbet Stock Price Today?
The Guerbet stock price today is 14.00.
What Is the Stock Symbol for Guerbet?
The stock symbol for Guerbet is ""GRBT.""
What Stock Exchange Does Guerbet Trade On?
Guerbet is listed and trades on the Paris stock exchange.
Is Guerbet a Good Stock to Buy?
Determining whether Guerbet—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GRBT quote. (ISIN: FR0000032526)
14.00
-0.28(-1.96%)
Real-time Data·
Fair Value
An estimate of a Guerbet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.92
14.20
52 wk Range
12.72
39.35
Earnings results expected in 6 days
1/2
Fair Value
An estimate of a Guerbet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.9214.20
52 wk Range
12.7239.35
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
GRBT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Guerbet's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
15.48
Upside
+10.54%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Guerbet Company Profile
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine; Elucirem, a macrocyclic gadolinium-based contrast agent; and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; and Patent Blue V, a blue dye. Further, it offers Qitexio, a lipiodol resistant medical devices consisting of medical syringes and a stopcock; Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables, as well as HydraVision, a digital imaging system. Guerbet SA was incorporated in 1926 and is headquartered in Villepinte, France.
Compare GRBT to Peers and Sector
Metrics to compare | GRBT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGRBTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 23.3x | 21.1x | −0.7x | |
PEG Ratio | −0.30 | 0.02 | 0.00 | |
Price/Book | 0.5x | 2.7x | 2.6x | |
Price / LTM Sales | 0.2x | 3.1x | 3.4x | |
Upside (Analyst Target) | 4.7% | 158.7% | 37.6% | |
Fair Value Upside | Unlock | 8.9% | 5.3% | Unlock |
Analyst Ratings
0 Buy
2 Hold
3 Sell
Ratings:
5 analysts
Overall Consensus
Sell
Analysts 12-Month Price Target:
Average 15.48
(+10.54% Upside)
Earnings
Latest Release
Sep 24, 2025
EPS / Forecast
0.21 / --
Revenue / Forecast
207.70M / --
People Also Watch
FAQ
What Stock Exchange Does Guerbet Trade On?
Guerbet is listed and trades on the Paris Stock Exchange stock exchange.
What Is the Stock Symbol for Guerbet?
The stock symbol for Guerbet is "GRBT."
What Is the Guerbet Market Cap?
As of today, Guerbet market cap is 176.42M.
What Is Guerbet's Earnings Per Share (TTM)?
The Guerbet EPS (TTM) is 0.61.
When Is the Next Guerbet Earnings Date?
Guerbet will release its next earnings report on 22 Oct 2025.
From a Technical Analysis Perspective, Is GRBT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Guerbet Stock Split?
Guerbet has split 5 times.
How Many Employees Does Guerbet Have?
Guerbet has 2842 employees.
What is the current trading status of Guerbet (GRBT)?
As of 17 Oct 2025, Guerbet (GRBT) is trading at a price of 14.00, with a previous close of 14.28. The stock has fluctuated within a day range of 13.92 to 14.20, while its 52-week range spans from 12.72 to 39.35.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.